XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements and Guarantees (Tables)
6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value Assets and Liabilities Measured On Recurring Basis [Table Text Block]
The following table presents, by level within the fair value hierarchy, certain of our significant financial assets and liabilities. The carrying values of cash and cash equivalents, accounts receivable, margin deposits, and accounts payable approximate fair value because of the short-term nature of these instruments. Therefore, these assets and liabilities are not presented in the following table.
Fair Value Measurements Using
Carrying
Amount
Fair
Value
Quoted
Prices In
Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
(Millions)
Assets (liabilities) at June 30, 2021:
Measured on a recurring basis:
ARO Trust investments$257 $257 $257 $— $— 
Additional disclosures:
Long-term debt, including current portion(23,234)(27,643)— (27,643)— 
Guarantees(40)(26)— (10)(16)
Assets (liabilities) at December 31, 2020:
Measured on a recurring basis:
ARO Trust investments$235 $235 $235 $— $— 
Additional disclosures:
Long-term debt, including current portion(22,344)(27,043)— (27,043)— 
Guarantees(40)(27)— (11)(16)
Fair Value Measurements, Nonrecurring [Table Text Block]
The following table presents impairments of equity-method investments associated with certain nonrecurring fair value measurements within Level 3 of the fair value hierarchy.
Impairments
Six Months Ended 
June 30,
SegmentDate of MeasurementFair Value20212020
(Millions)
Impairment of equity-method investments:
RMM (1)WestMarch 31, 2020$557 $243 
Brazos Permian II (1)WestMarch 31, 2020— 193 
Caiman II (2)Northeast G&PMarch 31, 2020191 229 
Appalachia Midstream Investments (2)Northeast G&PMarch 31, 20202,700 127 
Aux Sable (2)Northeast G&PMarch 31, 202039 
Laurel Mountain (2)Northeast G&PMarch 31, 2020236 10 
Discovery (2)Transmission & Gulf of MexicoMarch 31, 2020367 97 
Impairment of equity-method investments
$— $938 
_______________
(1)Following the previously described declining market conditions during the first quarter of 2020, we evaluated these investments for other-than-temporary impairment. The fair value was measured using an income approach. Both investees operate in primarily oil-driven basins where significant expected reductions in producer activities led to reduced estimates of expected future cash flows. Our fair value estimates also reflected discount rates of approximately 17 percent for these investments. We also considered any debt held at the investee level, and its impact to fair value. The industry weighted-average discount rates utilized were significantly influenced by the market declines previously discussed.
(2)Following the previously described declining market conditions during the first quarter of 2020, we evaluated these investments for other-than-temporary impairment. The impairments within our Northeast G&P segment are primarily associated with operations in wet-gas areas where producer drilling activities are influenced by NGL prices which historically trend with crude oil prices. The fair values of our investments in Caiman II and Aux Sable Liquid Products LP (Aux Sable) were estimated using a market approach, reflecting valuation multiples ranging from 5.0x to 6.2x EBITDA (weighted-average 6.0x). The fair values of the other investments, including gathering systems that are part of Appalachia Midstream Investments, were estimated using an income approach, with discount rates ranging from 9.7 percent to 13.5 percent (weighted-average 12.6 percent). We also considered any debt held at the investee level, and its impact to fair value. The assumed valuation multiples and industry weighted-average discount rates utilized were both significantly influenced by the market declines previously discussed.